Zobrazeno 1 - 10
of 164
pro vyhledávání: '"John MacDougall"'
Autor:
Shangzi Wang, Elana J Fertig, Allison A Fitzgerald, Veena Agarwal, Emily F Marcisak, Annie Zuo, Sandra A Jablonski, Melanie Loth, John MacDougall, Eugene Zhukovsky, Shubhendu Trivedi, Dimple Bhatia, Vince O'Neill, Louis M Weiner
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 11 (2021)
Externí odkaz:
https://doaj.org/article/0ee773f945a04c99afce61314f31fcd8
Autor:
Marcos Troncoso Costas, Ahmed Galib Reza, Hima Putta, Ankit Sharma, Gaurav Jain, Mark Smyth, Frank Smyth, John MacDougall, Colm Browning, Francisco Diaz Otero, Liam Barry
Publikováno v:
Optics Express. 30:20194
This paper describes the characterization of a novel directly modulated multi-section laser with a master-slave configuration. Amplitude and phase noise measurements show relative intensity noise values of around −150 dB/Hz and a 3-dB linewidth of
Autor:
Sanghamitra Choudhary, Hans E. Grossniklaus, Rhonda C. Kines, John Macdougall, Isabella Varsavsky, Elisabet de los Pinos, Stephen Monks, John T. Schiller, Debaditya Bhattacharya, Demitrios G Vavvas, Roger J. McLaughlin, Shin J. Kang, Sean Spring
Publikováno v:
Mol Cancer Ther
The work outlined herein describes AU-011, a novel recombinant papillomavirus-like particle (VLP) drug conjugate and its initial evaluation as a potential treatment for primary uveal melanoma. The VLP is conjugated with a phthalocyanine photosensitiz
Autor:
shubhendu Trivedi, Sandra A. Jablonski, Elana J. Fertig, Vince O'Neill, Allison A. Fitzgerald, Louis M. Weiner, Shangzi Wang, Melanie Loth, Veena R Agarwal, Eugene Zhukovsky, Emily F Marcisak, John MacDougall, Annie Zuo, Dimple Bhatia
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 11 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundPancreatic ductal adenocarcinoma (PDAC) is projected to be the second leading cause of cancer death in the USA by 2030. Immune checkpoint inhibitors fail to control most PDAC tumors because of PDAC’s extensive immunosuppressive microenvir
Autor:
Mustapha Zahir, Efstratios Kehayas, Adrian Norman, Paul Naylor, Sébastien Lhuillier, Lip Sun How, Philip Henderson, Alain Bensoussan, John MacDougall
Publikováno v:
International Conference on Space Optics — ICSO 2018.
Following a program funded by the European Space Agency, a novel laser-diode module has been created and tested to ESCC-23201-compliant space standards. Manufactured by Gooch & Housego, the module is set for imminent entry to the European space marke
Autor:
John MacDougall
Publikováno v:
Challenges and Innovations in U.S. Health Care ISBN: 9780429048883
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edf811a55db595db5292ff44fcfd9ffa
https://doi.org/10.4324/9780429048883-7
https://doi.org/10.4324/9780429048883-7
Publikováno v:
Journal of Geophysical Research: Space Physics. 121:9030-9050
This statistical study examines the solar wind dependence of total electron content (TEC) variations arising from mesoscale (tens to hundreds of kilometers) structuring of the polar cap ionosphere. Six years of TEC measurements were collected from fi
Publikováno v:
Journal of Geophysical Research: Space Physics. 121:4748-4768
This paper presents statistical characteristics (occurrence rate, amplitude, and frequency) of low-frequency (
Autor:
Hemant Banga, Veena R Agarwal, shubhendu Trivedi, Diane Healy, Vince O'Neill, Sreenivas Adurthi, Zeenia Jagga, John MacDougall, Dimple Bhatia
Publikováno v:
Cancer Research. 80:962-962
The oral DPP8/9 inhibitor BXCL701 in combination with an anti-PD-1 antibody (aPD-1) [AACR 2017] or in triple combination with aPD-1 and pegylated IL-2 (NKTR-214) [ASCO 2018] has demonstrated inhibition of tumor growth or complete regression respectiv
Autor:
Reham Ajina, Shangzi Wang, John MacDougall, Veena R Agarwal, Allison Fitzgerald, Sandra A. Jablonsk, Vince O'Neill, Louis M. Weiner
Publikováno v:
Cancer Research. 80:6636-6636
PDAC is typically resistant to chemotherapy and immunotherapy; therefore, novel strategies are needed to enhance therapeutic response. BXCL701 is a well-studied inhibitor of dipeptidyl peptidases 4, 8, 9, and Fibroblast Activation Protein, and has be